BPMX - BioPharmX Corp.

0.0001
0   0%

Share volume: 446
Last Updated: 03-21-2024

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.00
P/E Ratio 
N/A
DAY RANGE
$0.51 - $0.51
EPS 
-$0.83
52 WEEK RANGE
$0.25 - $1.18
52 WEEK CHANGE
-$48.48
MARKET CAP 
9.322 M
YIELD 
N/A
SHARES OUTSTANDING 
18.278 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$15,950,315
AVERAGE 10 VOLUME 
$9,223,899
AVERAGE 30 VOLUME 
$3,644,005
Company detail
CEO: Steven M. Bosacki
Region: US
Website: http://www.biopharmx.com
Employees: 3
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry:
Sector:

BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA.

Recent news